Shift Bioscience
Rejina Khan is a Senior Research Scientist at Shift Bioscience since January 2025, previously holding senior scientific roles at Adaptimmune from November 2020 to December 2024, including Senior Scientist and Protein Engineering Scientist. Khan completed a PhD in Biochemistry at the University of Kent, where a project under the supervision of Dr. Ben Goult focused on the characterization of proteins involved in cell-extracellular matrix adhesion complexes. As a Graduate Teaching Assistant and Laboratory Demonstrator at the University of Kent, Khan contributed over 200 teaching hours and completed the Associate Fellowship Scheme by the Higher Education Academy. A brief research stint as a Visiting Researcher took place at Centro de Investigación del Cáncer in 2019, enhancing skills in protein crystallization and X-ray crystallography. Prior to academic pursuits, Khan worked as a Customer Assistant at Marks and Spencer from July 2014 to September 2018.
This person is not in any teams
Shift Bioscience
Shift Bioscience is unlocking safe rejuvenation with cell simulations. Cellular reprogramming is a powerful biological pathway that can reverse ageing and age-driven diseases in the dish but is not yet safe for clinical use. Our team based in Cambridge UK has pioneered the first high throughput, high accuracy ageing biomarker, which can be leveraged in AI-based cell simulations to identify drug targets for safe rejuvenation.